334 related articles for article (PubMed ID: 32760201)
1. The Role of Interleukins in Colorectal Cancer.
Li J; Huang L; Zhao H; Yan Y; Lu J
Int J Biol Sci; 2020; 16(13):2323-2339. PubMed ID: 32760201
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γ.
Petanidis S; Anestakis D; Argyraki M; Hadzopoulou-Cladaras M; Salifoglou A
PLoS One; 2013; 8(9):e73616. PubMed ID: 24040001
[TBL] [Abstract][Full Text] [Related]
3. IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients.
Song B; Ma Y; Liu X; Li W; Zhang J; Liu J; Han J
Tumour Biol; 2016 Jan; 37(1):1349-56. PubMed ID: 26293897
[TBL] [Abstract][Full Text] [Related]
4. LINC00511-dependent inhibition of IL-24 contributes to the oncogenic role of HNF4α in colorectal cancer.
Lu Y; Yu Y; Liu F; Han Y; Xue H; Sun X; Jiang Y; Tian Z
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G338-G350. PubMed ID: 33052062
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of interleukin-21 along colorectal adenoma-carcinoma sequence and its predicating significance in patients with sporadic colorectal cancer.
Cui G; Yuan A; Zhu L; Florholmen J; Goll R
Clin Immunol; 2017 Oct; 183():266-272. PubMed ID: 28887120
[TBL] [Abstract][Full Text] [Related]
6. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
[TBL] [Abstract][Full Text] [Related]
7. Functional roles of cytokines in infectious disease associated colorectal carcinogenesis.
Ong CY; Abdalkareem EA; Khoo BY
Mol Biol Rep; 2022 Feb; 49(2):1529-1535. PubMed ID: 34981335
[TBL] [Abstract][Full Text] [Related]
8. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
[TBL] [Abstract][Full Text] [Related]
9. Riproximin: A type II ribosome inactivating protein with anti-neoplastic potential induces IL24/MDA-7 and GADD genes in colorectal cancer cell lines.
Pervaiz A; Adwan H; Berger MR
Int J Oncol; 2015 Sep; 47(3):981-90. PubMed ID: 26151662
[TBL] [Abstract][Full Text] [Related]
10. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
Setrerrahmane S; Xu H
Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
[TBL] [Abstract][Full Text] [Related]
11. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
[TBL] [Abstract][Full Text] [Related]
12. IL-33/ST2 pathway contributes to metastasis of human colorectal cancer.
Liu X; Zhu L; Lu X; Bian H; Wu X; Yang W; Qin Q
Biochem Biophys Res Commun; 2014 Oct; 453(3):486-92. PubMed ID: 25280997
[TBL] [Abstract][Full Text] [Related]
13. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8.
Wu T; Wang Z; Liu Y; Mei Z; Wang G; Liang Z; Cui A; Hu X; Cui L; Yang Y; Liu CY
Clin Immunol; 2014 Oct; 154(2):116-26. PubMed ID: 25063444
[TBL] [Abstract][Full Text] [Related]
15. Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.
Ingram N; Northwood EL; Perry SL; Marston G; Snowden H; Taylor JC; Scott N; Bishop DT; Coletta PL; Hull MA
Carcinogenesis; 2013 Oct; 34(10):2341-9. PubMed ID: 23784081
[TBL] [Abstract][Full Text] [Related]
16. Protein Expression and Genetic Variation of
Shamoun L; Kolodziej B; Andersson RE; Dimberg J
Anticancer Res; 2018 Jan; 38(1):321-328. PubMed ID: 29277790
[TBL] [Abstract][Full Text] [Related]
17. Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis.
Jain SM; Deka D; Das A; Paul S; Pathak S; Banerjee A
Dig Dis Sci; 2023 Aug; 68(8):3220-3236. PubMed ID: 37277647
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
[TBL] [Abstract][Full Text] [Related]
19. Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients.
Mao H; Pan F; Guo H; Bu F; Xin T; Chen S; Guo Y
Tumour Biol; 2016 Sep; 37(9):12223-12230. PubMed ID: 27235120
[TBL] [Abstract][Full Text] [Related]
20. The IL-22 gene rs2227478 polymorphism significantly decreases the risk of colorectal cancer in a Han Chinese population.
Jin Y; Meng L; Yang H; Cheng S; Xiao Y; Wang X; Feng X; Xiong Q; Chen B
Pathol Res Pract; 2021 Dec; 228():153690. PubMed ID: 34808559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
